Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 318

Monzo makes good on $144m round

Orange Digital Ventures and Stripe both returned for a $144m round that doubled the digital bank's valuation to $2.5bn.

Jun 25, 2019

Woodford suffers Immunocore devaluation

The combined value of Woodford's stakes in immunotherapy developer Immunocore has reportedly crashed to $57m from around $112m.

Jun 25, 2019

DTCP draws LPs for $350m second fund

Deutsche Telekom's corporate venturing vehicle has sourced capital from limited partners including SK Telecom and Zeiss for a newly formed VC and growth fund.

Jun 25, 2019

CIC invests $58.5m within a year

The total size of investments from the Cambridge-allied patient capital fund rose from $45.8m in 2017-2018, following a $196m fundraising effort earlier this year.

Jun 25, 2019

Pharrowtech connects to Imec.xpand for $7m

Imec.xpand has co-led a $7m seed round for Pharrowtech, which is commercialising millimeter wave wireless technology based on research at Imec and Vrije Universiteit Brussel.

Jun 25, 2019

Vestiaire Collective completes BPIfrance-led round

Condé Nast-backed premium second-hand marketplace Vestiaire Collective has lifted its funding tally to $176m with a $45.2m round co-led by BPIfrance.

Jun 24, 2019

Oxford experiments with Lab10x

Lab10x will accelerate the commercialisation of digital therapeutics and data-driven drug discovery, and is being launched in partnership with Sensyne Health and Evotec.

Jun 24, 2019

Corporate venturing deal net: 17-21 June 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Jun 21, 2019

Daily deal net: June 21, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Jun 21, 2019

Vienna pair press with P4 Therapeutics

Building on joint research from University of Vienna and Medical University of Vienna, P4 is creating next-generation platinum chemotherapy with fewer side-effects than current approaches.

Jun 21, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here